BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 17391223)

  • 1. Different types of renal dysfunction in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kowalczyk J; Lenarczyk R; Kowalski O; Sredniawa B; Musialik-Lydka A; Gasior M; Polonski L; Zembala M; Gumprecht J; Kalarus Z
    J Interv Cardiol; 2007 Apr; 20(2):143-52. PubMed ID: 17391223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification according to the type of impaired renal function in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kowalczyk J; Lenarczyk R; Kowalski O; Swiatkowski A; Stabryła-Deska J; Kurek T; Honisz G; Kukulski T; Gasior M; Kalarus Z
    Kardiol Pol; 2007 Jun; 65(6):635-43; discussion 644. PubMed ID: 17629825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of anemia in high-risk groups of patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kurek T; Lenarczyk R; Kowalczyk J; Swiatkowski A; Kowalski O; Stabryła-Deska J; Honisz G; Lekston A; Kalarus Z; Kukulski T
    Am J Cardiol; 2010 Mar; 105(5):611-8. PubMed ID: 20185005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between severity of renal impairment and 2-year outcomes after sirolimus-eluting stent implantation.
    Ota T; Umeda H; Yokota S; Miyata S; Takamura A; Sugino S; Hayashi K; Ishiki R; Takeichi Y; Iwase M; Inagaki H; Murohara T
    Am Heart J; 2009 Jul; 158(1):92-8. PubMed ID: 19540397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction.
    Marenzi G; Lauri G; Assanelli E; Campodonico J; De Metrio M; Marana I; Grazi M; Veglia F; Bartorelli AL
    J Am Coll Cardiol; 2004 Nov; 44(9):1780-5. PubMed ID: 15519007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of advanced chronic kidney disease on in-hospital mortality following percutaneous coronary intervention for acute myocardial infarction.
    Vasu S; Gruberg L; Brown DL
    Catheter Cardiovasc Interv; 2007 Nov; 70(5):701-5. PubMed ID: 17932900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention.
    Nikolsky E; Mehran R; Turcot D; Aymong ED; Mintz GS; Lasic Z; Lansky AJ; Tsounias E; Moses JW; Stone GW; Leon MB; Dangas GD
    Am J Cardiol; 2004 Aug; 94(3):300-5. PubMed ID: 15276092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of complete revascularization in patients with acute myocardial infarction treated with percutaneous coronary intervention.
    Kalarus Z; Lenarczyk R; Kowalczyk J; Kowalski O; Gasior M; Was T; Zebik T; Krupa H; Chodór P; Poloński L; Zembala M
    Am Heart J; 2007 Feb; 153(2):304-12. PubMed ID: 17239694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis in diabetic patients with acute myocardial infarction treated invasively is related to renal function.
    Kowalczyk J; Lenarczyk R; Strojek K; Zielinska T; Gumprecht J; Sedkowska A; Kukulski T; Swierad M; Kowalski O; Sredniawa B; Polonski L; Zembala M; Kalarus Z
    Med Sci Monit; 2010 Feb; 16(2):CR67-74. PubMed ID: 20110917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of kidney function in patients with ST-elevation and non-ST-elevation acute myocardial infarction treated with percutaneous coronary intervention.
    Seyfarth M; Kastrati A; Mann JF; Ndrepepa G; Byrne RA; Schulz S; Mehilli J; Schömig A
    Am J Kidney Dis; 2009 Nov; 54(5):830-9. PubMed ID: 19592145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of renal function on the long-term clinical course of patients who underwent percutaneous coronary intervention.
    Papafaklis MI; Naka KK; Papamichael ND; Kolios G; Sioros L; Sclerou V; Katsouras CS; Michalis LK
    Catheter Cardiovasc Interv; 2007 Feb; 69(2):189-97. PubMed ID: 17253600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal medical therapy with or without percutaneous coronary intervention for patients with stable coronary artery disease and chronic kidney disease.
    Sedlis SP; Jurkovitz CT; Hartigan PM; Goldfarb DS; Lorin JD; Dada M; Maron DJ; Spertus JA; Mancini GB; Teo KK; O'Rourke RA; Boden WE; Weintraub WS;
    Am J Cardiol; 2009 Dec; 104(12):1647-53. PubMed ID: 19962469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death.
    Hakeem A; Bhatti S; Dillie KS; Cook JR; Samad Z; Roth-Cline MD; Chang SM
    Circulation; 2008 Dec; 118(24):2540-9. PubMed ID: 19047585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction.
    Lambert ND; Sacrinty MT; Ketch TR; Turner SJ; Santos RM; Daniel KR; Applegate RJ; Kutcher MA; Sane DC
    Am Heart J; 2009 Apr; 157(4):688-94. PubMed ID: 19332197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry).
    Cardarelli F; Bellasi A; Ou FS; Shaw LJ; Veledar E; Roe MT; Morris DC; Peterson ED; Klein LW; Raggi P
    Am J Cardiol; 2009 Mar; 103(6):766-71. PubMed ID: 19268729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of vascular inflammation and chronic kidney disease for the prediction of long-term death after percutaneous coronary intervention.
    Fathi RB; Gurm HS; Chew DP; Gupta R; Bhatt DL; Ellis SG
    Am Heart J; 2005 Dec; 150(6):1190-7. PubMed ID: 16338257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of admission creatinine level on clinical outcomes of patients with acute ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention with drug-eluting stent implantation.
    Zhang Q; Zhang RY; Shen J; Zhang JS; Hu J; Yang ZK; Zhang X; Zheng AF; Shen WF
    Chin Med J (Engl); 2008 Dec; 121(23):2379-83. PubMed ID: 19102952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables.
    Dangas G; Iakovou I; Nikolsky E; Aymong ED; Mintz GS; Kipshidze NN; Lansky AJ; Moussa I; Stone GW; Moses JW; Leon MB; Mehran R
    Am J Cardiol; 2005 Jan; 95(1):13-9. PubMed ID: 15619387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of admission glomerular filtration rate on the development of poor myocardial perfusion after primary percutaneous intervention in patients with acute myocardial infarction.
    Celik T; Iyisoy A; Yuksel CU; Kilic S; Yilmaz MI; Akgul EO; Jata B; Isik E
    Coron Artery Dis; 2008 Dec; 19(8):543-9. PubMed ID: 19005288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.